Compare AWI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AWI | RGEN |
|---|---|---|
| Founded | 1860 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.6B |
| IPO Year | 1994 | 1995 |
| Metric | AWI | RGEN |
|---|---|---|
| Price | $176.58 | $182.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $207.50 | $167.67 |
| AVG Volume (30 Days) | 341.3K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | 17.61 | ★ 286.96 |
| EPS | ★ 3.81 | 0.24 |
| Revenue | ★ $1,620,800,000.00 | $141,236,000.00 |
| Revenue This Year | $10.32 | $14.30 |
| Revenue Next Year | $6.71 | $14.52 |
| P/E Ratio | ★ $46.66 | $748.08 |
| Revenue Growth | 12.11 | ★ 35.10 |
| 52 Week Low | $150.28 | $100.99 |
| 52 Week High | $206.08 | $188.73 |
| Indicator | AWI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 72.83 |
| Support Level | $161.26 | $156.65 |
| Resistance Level | $182.55 | $188.73 |
| Average True Range (ATR) | 3.48 | 6.28 |
| MACD | -1.33 | 0.78 |
| Stochastic Oscillator | 6.59 | 73.43 |
Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.